Related Experiment Videos
Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques.
Mark K Ferguson1, Amy G Lehman
1Department of Surgery, The University of Chicago, Chicago, Illinois 60637, USA. mferguso@surgery.bsd.uchicago.edu
The Annals of Thoracic Surgery
|December 12, 2003
Summary
For early-stage lung cancer, sleeve lobectomy offers better survival and quality of life than pneumonectomy. This lung cancer surgery is also more cost-effective, making it a preferred option for eligible patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Health Economics
Background:
- The optimal surgical approach for early-stage lung cancer with acceptable lung function remains debated.
- Sleeve lobectomy and pneumonectomy are the primary surgical options considered.
Purpose of the Study:
- To compare the long-term outcomes and cost-effectiveness of sleeve lobectomy versus pneumonectomy.
- To inform clinical decision-making for early-stage lung cancer patients.
Main Methods:
- A meta-analysis of studies published between 1990 and 2003 was conducted.
- A decision model evaluated 5-year survival, quality-adjusted life years (QALYs), and cost-effectiveness.
- Sensitivity analyses were performed to assess the robustness of the findings.
Main Results:
- Sleeve lobectomy demonstrated a 3.5% survival advantage at 5 years.
- Sleeve lobectomy showed a significant advantage in Quality-Adjusted Life Years (QALYs), with a 1.53 QALY advantage.
- The incremental cost-effectiveness ratio for sleeve lobectomy was favorable at $1,300/QALY.
Conclusions:
- Sleeve lobectomy provides superior long-term survival and quality of life compared to pneumonectomy in select early-stage lung cancer patients.
- Sleeve lobectomy is a more cost-effective surgical option for anatomically appropriate lung cancer resections.
- These findings support sleeve lobectomy as a preferred surgical strategy for eligible patients.